Cancer Research Center – Roanoke
CANCER RESEARCH CENTER – ROANOKE
About the Cancer Research Center – Roanoke
Cancer research is woven through the work of numerous laboratories at the Fralin Biomedical Research Institute. Investigators strive to understand the molecular mechanisms underlying the genetic and environmental factors that encourage cancer growth, as well as how cancer multiplies and migrates throughout the body. From childhood cancers to breast cancer to brain cancers, including the deadliest of all, glioblastoma, researchers at the institute are developing methods to make cancer cells more vulnerable to existing treatments and innovating completely new treatments to halt cancer and prevent its return.
The center is led by Jennifer Munson, Ph.D., whose research focuses on the role of interstitial fluid flow in tumor development.
Center Contacts
- Director: Jenny Munson, Ph.D
- Administrative Coordinator: Shelby Yancey
-
Home Item
Jenny Munson, Ph.D. , homeProfessor, Director, Cancer Research Center – Roanoke
-
Home Item
Finkielstein Lab , homeThe Finkielstein lab studies how disruption of the body's circadian rhythm influences cancer initiation and progression.
-
Home Item
Lamouille Lab , homeThe Lamouille Lab studies ways to deregulate cancer cell communication and is developing new therapeutic strategies to stall cancer stem cell proliferation and metastases.
-
Home Item
Lee Lab , homeThe Lee lab develops various types of biomaterials to enhance anti-tumor immune responses without toxic effects, and to understand their therapeutic mechanisms in a range of cancers.
-
Home Item
Munson Lab , homeThe Munson Lab studies the tumor microenvironment in cancers, including glioblastoma, the deadliest form of brain cancer. Our research focuses on the emerging research area of fluid flow.
-
Home Item
Sheng Lab , homeResearchers in the Sheng Laboratory are particularly interested in glioblastoma multiforme.
-
Home Item
Wu Lab , homeThe Advances in Technology and Drug Delivery Initiative Laboratory, led by Cheng-Chia "Fred" Wu, M.D., Ph.D., studies the translation of novel drug delivery technologies to treating children with brain tumors.
-
Article Item
-
Article Item
-
Article Item
-
Article ItemTranslational biology, medicine, and health student pursues science close to home with new grant , article
Mason Wheeler, a doctoral candidate in the Pfleger Lab at the Fralin Biomedical Research Institute at VTC, earned a prestigious Ruth Kirschstein Predoctoral Fellowship from the National Heart, Lung, and Blood Institute, part of the National Institutes of Health.
Date: Oct 31, 2024 -
Article ItemVirginia Tech Carilion School of Medicine receives recognition for inclusive initiatives , article
INSIGHT Into Diversity magazine honors the school for the seventh straight year.
Date: Oct 03, 2024 -
Article ItemVirginia Tech students named 2024 Astronaut Scholars , article
College of Science students Chloe Nyhart and Stephen Argauer earned spots in the highly competitive 2024 class of Astronaut Scholars.
Date: Sep 26, 2024 -
Article ItemVirginia Tech award supports innovation in brain cancer treatment , article
Cairina Inc. co-founder Caleb Stine received a Presidential Postdoctoral Fellowship Award that puts the Fralin Biomedical Research Institute spinoff a step closer to making its research available to surgeons and oncologists.
Date: Sep 25, 2024 -
Article ItemCancer researcher wants to make treatment better, more accessible , article
DaeYong Lee, assistant professor at the Fralin Biomedical Research Institute at VTC, aims to use biomaterials to improve cancer immunotherapy and reduce disparities in treatment outcomes.
Date: Sep 20, 2024 -
Article ItemScientist awarded National Institutes of Health grant to examine cancer-related enzyme , article
Kathleen Mulvaney, assistant professor with the Fralin Biomedical Research Institute’s Cancer Research Center — D.C., will investigate the basic biology of PRMT5, an enzyme that can be found in 15 percent of human cancers.
Date: Sep 10, 2024 -
Article ItemTeam of scientists awarded prize for biomedical research innovation , article
A multi-university team including Jennifer Munson of the Fralin Biomedical Research Institute earned a Complement Animal Research in Experimentation Challenge prize with a proposal for a novel platform for studying and treating neuro-immune infections including the flu, COVID-19, potential biothreats, and conditions such as Alzheimer’s, multiple sclerosis, and brain cancer.
Date: Aug 28, 2024
Page 1 of 11 | 107 Results
-
Redirect Item
-
Redirect Item
-
Redirect Item
-
Redirect Item
-
Redirect Item
-
Redirect Item
-
Redirect Item
-
Redirect Item
-
Redirect Item
-
Redirect Item
-
Redirect Item
-
Redirect Item
-
Redirect Item
-
Redirect Item
-
Redirect Item
-
Redirect Item
-
Redirect Item
-
Redirect Item
-
Redirect Item
-
Redirect Item
-
Redirect Item
-
Redirect Item
-
Redirect Item
-
Redirect Item
-
Redirect Item
-
Redirect Item
-
Redirect Item
-
Redirect Item
-
Redirect Item
-
Redirect Item
-
Redirect Item
-
Redirect Item
-
Redirect Item
-
Redirect Item
-
Redirect Item
-
Redirect Item
-
Redirect Item
-
Redirect Item
-
Redirect Item
-
Redirect Item
-
Redirect Item
-
Redirect Item
-
Redirect Item
-
Redirect ItemWSLS TV: Virginia Tech fraternity funds research fellowship , redirect Date: Feb 17, 2023
-
Redirect Item
-
Redirect Item
-
Redirect Item
-
Redirect Item
-
Redirect Item
-
Redirect Item
-
Redirect Item
-
Redirect ItemMedi Magazine: Glioblastoma: new treatment strategy , redirect Date: Jan 16, 2022
-
Redirect Item
-
Redirect Item
-
Redirect Item
-
Redirect Item
-
Redirect Item
-
Redirect Item
-
Redirect Item
-
Redirect Item
-
Redirect Item
-
Redirect Item
-
Redirect Item
-
Redirect Item
-
Redirect Item
-
Redirect Item
-
Redirect Item
-
Redirect Item
-
Redirect Item
-
Redirect Item
-
Redirect Item
-
Redirect ItemBioengineer: $100,000 to fund collaborative cancer research , redirect Date: Jan 14, 2021
-
Redirect ItemScienmag: $100,000 To Fund Collaborative Cancer Research , redirect Date: Jan 14, 2021
-
Redirect Item7th Space: $100,000 to fund collaborative cancer research , redirect Date: Jan 14, 2021
-
Redirect Item
-
Redirect Item
-
Redirect ItemSuper Human Radio: Study Shows Jet Lag Impairs The Immune System , redirect Date: Oct 30, 2020
-
Redirect Item
-
Redirect Item
-
Redirect Item
-
Redirect Item
-
Redirect ItemNeuroscience News: Jet Lag Conditions Impair Immune Response , redirect Date: Oct 14, 2020
-
Redirect Item
-
Redirect Item
-
Redirect Item
-
Redirect Item
-
Redirect Item
-
Redirect Item
-
Redirect Item
-
Redirect Item
-
Redirect Item
-
Redirect ItemWVTF: Potential New Treatment for Deadliest Brain Diseases , redirect Date: Dec 05, 2018
-
Redirect Item
-
Redirect Item
-
Redirect Item
-
Redirect Item
-
Redirect ItemWVTF: Glioblastoma canine clinical trials , redirect Date: Nov 16, 2015
-
Redirect Item
-
Home Item
A Novel Bispecific Antibody to Target the Brain Tumor Microenvironment , homeMay 2, 2025, 11:00 a.m. | Khuson Yun, Ph.D., Associate Professor, Department of Neurology, Houston Methodist Chair, Neurodegenerative Disease Research, Houston Methodist Research Institute, Weill Cornell Medical College | Co-Sponsored by the Fralin Biomedical Research Institute Cancer Research Center – Roanoke
-
Home Item
Targeting Acquired Dependencies During Tumor Evolution , homeJune 6, 2025, 11:00 a.m. | Kris Wood, Ph.D., Associate Professor, Department of Pharmacology and Cancer Biology, Duke University School of Medicine | Co-Sponsored by the Fralin Biomedical Research Institute Cancer Research Center – D.C.